PL2047855T3 - Farmaceutyczny skład antyblastyczny, antybakteryjny i wirusobójczy (odmiany) - Google Patents

Farmaceutyczny skład antyblastyczny, antybakteryjny i wirusobójczy (odmiany)

Info

Publication number: PL2047855T3
Authority: PL; Poland
Prior art keywords: tumoral; antibacterial; acid; variants; pharmaceutical composition
Prior art date: 2006-07-12

Application number

PL07794063T

Other languages

English (en)

Inventor

Vladimir Mikhaylovich Plotnikov

Original Assignee

Badulin Nikolay Aleksandrovich

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-07-12

Filing date

2007-06-21

Publication date

2011-03-31

2007-06-21 Application filed by Badulin Nikolay Aleksandrovich filed Critical Badulin Nikolay Aleksandrovich

2011-03-31 Publication of PL2047855T3 publication Critical patent/PL2047855T3/pl

Links

230000000844 anti-bacterial effect Effects 0.000 title abstract 3
230000000259 anti-tumor effect Effects 0.000 title abstract 3
230000000840 anti-viral effect Effects 0.000 title abstract 3
239000008194 pharmaceutical composition Substances 0.000 title abstract 3
PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 abstract 4
VKYKSIONXSXAKP-UHFFFAOYSA-N hexamethylenetetramine Chemical compound C1N(C2)CN3CN1CN2C3 VKYKSIONXSXAKP-UHFFFAOYSA-N 0.000 abstract 4
SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 abstract 4
239000000203 mixture Substances 0.000 abstract 3
239000003795 chemical substances by application Substances 0.000 abstract 2
235000010299 hexamethylene tetramine Nutrition 0.000 abstract 2
239000004312 hexamethylene tetramine Substances 0.000 abstract 2
229960003512 nicotinic acid Drugs 0.000 abstract 2
235000001968 nicotinic acid Nutrition 0.000 abstract 2
239000011664 nicotinic acid Substances 0.000 abstract 2
229910001961 silver nitrate Inorganic materials 0.000 abstract 2
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
RAXXELZNTBOGNW-UHFFFAOYSA-N 1H-imidazole Chemical compound C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 abstract 1
DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Chemical compound OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 abstract 1
AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 abstract 1
PMLJIHNCYNOQEQ-REOHCLBHSA-N L-aspartic 1-amide Chemical compound NC(=O)[C@@H](N)CC(O)=O PMLJIHNCYNOQEQ-REOHCLBHSA-N 0.000 abstract 1
229910017912 NH2OH Inorganic materials 0.000 abstract 1
239000004133 Sodium thiosulphate Substances 0.000 abstract 1
229960005261 aspartic acid Drugs 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
238000009472 formulation Methods 0.000 abstract 1
AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 abstract 1
235000019345 sodium thiosulphate Nutrition 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/132—Amines having two or more amino groups, e.g. spermidine, putrescine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/282—Platinum compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/38—Silver; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Inorganic Chemistry (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Dermatology (AREA)
Virology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

PL07794063T 2006-07-12 2007-06-21 Farmaceutyczny skład antyblastyczny, antybakteryjny i wirusobójczy (odmiany) PL2047855T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
RU2006125085/15A RU2319491C1 (ru)	2006-07-12	2006-07-12	Противоопухолевая, антибактериальная и антивирусная фармацевтическая композиция (ее варианты)
PCT/RU2007/000341 WO2008007999A1 (en)	2006-07-12	2007-06-21	Anti-tumoral, antibacterial and antiviral pharmaceutical composition (variants)
EP07794063A EP2047855B1 (de)	2006-07-12	2007-06-21	Antitumorale, antibakterielle und antivirale pharmazeutische zusammensetzung (varianten)

Publications (1)

Publication Number	Publication Date
PL2047855T3 true PL2047855T3 (pl)	2011-03-31

Family

ID=38923476

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL07794063T PL2047855T3 (pl)	2006-07-12	2007-06-21	Farmaceutyczny skład antyblastyczny, antybakteryjny i wirusobójczy (odmiany)

Country Status (11)

Country	Link
US (1)	US20090136590A1 (pl)
EP (1)	EP2047855B1 (pl)
CN (1)	CN101516384B (pl)
AT (1)	ATE478673T1 (pl)
DE (1)	DE502007004869D1 (pl)
EA (1)	EA014603B1 (pl)
PL (1)	PL2047855T3 (pl)
RU (1)	RU2319491C1 (pl)
SI (1)	SI2047855T1 (pl)
UA (1)	UA90965C2 (pl)
WO (1)	WO2008007999A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8895610B1 (en)	2007-05-18	2014-11-25	Heldi Kay	Platinum (IV) compounds targeting zinc finger domains
RU2468447C1 (ru) *	2011-06-27	2012-11-27	Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения и социального развития Российской Федерации (ФГБУ "РНИОИ" Минздравсоцразвития России)	Способ индукции цитотоксического действия на опухолевые клетки
RU2549495C1 (ru) *	2014-06-27	2015-04-27	Общество с ограниченной ответственностью "НаноФарм-про"	Способ получения средства на основе гексаметилентетрамина и наноселена, оказывающего стимулирующее действие на клетки организма
RU2593587C1 (ru) *	2015-03-30	2016-08-10	Евгений Владимирович Плотников	Антиоксидантная композиция(варианты)
RU2608130C1 (ru) *	2016-02-02	2017-01-13	Федеральное государственное автономное образовательное учреждение высшего образования "Национальный исследовательский Томский политехнический университет"	Способ и фармацевтическая композиция для лечения вирусного лейкоза крупного рогатого скота

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4866092A (en) *	1985-06-26	1989-09-12	American Cyanamid Company	Platinum complexes of amines with novel dibasic acids
US4675336A (en) *	1985-06-26	1987-06-23	American Cyanamid Company	Platinum complexes of amines with dibasic acids
GB8810173D0 (en) *	1988-04-29	1988-06-02	Norsk Hydro As	Pharmaceutical compositions with anti-cancer activity & method for treatment of cancer
US4946954A (en)	1989-01-17	1990-08-07	Georgetown University	Platinum pharmaceutical agents
RU2114858C1 (ru) *	1995-06-26	1998-07-10	Владимир Михайлович Плотников	Производные дихлорида цис-диамминдиимидазолил платины, проявляющие антипролиферативную активность, и способ их получения
RU2094048C1 (ru) *	1995-08-18	1997-10-27	Владимир Михайлович Плотников	Цитостатический и антивирусный состав
RU2181050C2 (ru)	1999-05-21	2002-04-10	Плотников Владимир Михайлович	Противоопухолевая и антибактериальная композиция
WO2004110361A2 (en) *	2003-05-20	2004-12-23	Hong Ji Zhong	Anticancer compositions comprising methenamine
RU2242977C1 (ru) *	2003-09-30	2004-12-27	Плотников Евгений Владимирович	Антивирусная и бактерицидная композиция
WO2006013887A1 (ja) *	2004-08-03	2006-02-09	Chugai Seiyaku Kabushiki Kaisha	新規イミダゾリジン誘導体

2006
- 2006-07-12 RU RU2006125085/15A patent/RU2319491C1/ru not_active IP Right Cessation
2007
- 2007-06-21 AT AT07794063T patent/ATE478673T1/de active
- 2007-06-21 DE DE502007004869T patent/DE502007004869D1/de active Active
- 2007-06-21 UA UAA200901065A patent/UA90965C2/ru unknown
- 2007-06-21 EP EP07794063A patent/EP2047855B1/de not_active Not-in-force
- 2007-06-21 SI SI200730419T patent/SI2047855T1/sl unknown
- 2007-06-21 WO PCT/RU2007/000341 patent/WO2008007999A1/ru not_active Ceased
- 2007-06-21 CN CN2007800260079A patent/CN101516384B/zh not_active Expired - Fee Related
- 2007-06-21 EA EA200900077A patent/EA014603B1/ru not_active IP Right Cessation
- 2007-06-21 PL PL07794063T patent/PL2047855T3/pl unknown
2008
- 2008-12-30 US US12/346,172 patent/US20090136590A1/en not_active Abandoned

Also Published As

Publication number	Publication date
DE502007004869D1 (de)	2010-10-07
US20090136590A1 (en)	2009-05-28
UA90965C2 (ru)	2010-06-10
SI2047855T1 (sl)	2011-02-28
EA014603B1 (ru)	2010-12-30
CN101516384B (zh)	2012-07-04
EA200900077A1 (ru)	2009-04-28
CN101516384A (zh)	2009-08-26
WO2008007999A1 (en)	2008-01-17
EP2047855B1 (de)	2010-08-25
EP2047855A1 (de)	2009-04-15
RU2319491C1 (ru)	2008-03-20
ATE478673T1 (de)	2010-09-15
EP2047855A4 (de)	2009-11-11

Publication	Publication Date	Title
HRP20200777T1 (hr)	2020-07-24	Formulacije koje sadrže triazinone i željezo
SG157406A1 (en)	2009-12-29	Oral medicament for the modified release of at least one active principle, in multi-microcapsule form
SI2529622T1 (en)	2018-06-29	Inhibitors of bruton's tyrosine kinase
HRP20130406T1 (hr)	2013-06-30	Medikamenti s aktivnošä†u prema receptoru hm74a
EA200700049A1 (ru)	2007-04-27	Препаративные формы оральных лекарственных форм мемантина с модифицированным высвобождением
PE20140854A1 (es)	2014-07-19	Formas de dosificacion farmaceutica
MXPA05013637A (es)	2006-02-24	Inhibidores gsk-3 y usos de los mismos.
GT200900154A (es)	2012-01-17	Derivados de 2,3-dihidroimidozo [1,2-c] quinizolina sustituidos de utilidad en el tratamiento de trastornos hiperproliferativos y enfermedades asociadas con la angiogenesis
IL197393A (en)	2013-09-30	History of pyridine-4-ram, containing and using pharmaceutical preparations for the preparation of drugs for the treatment of immune-related diseases
DE602005021770D1 (de)	2010-07-22	Indol-1-yl-essigsäurederivate
SI2047855T1 (sl)	2011-02-28	Antitumorski, antibakterijski in antivirusni farmacevtski sestavek (variante)
EP1750862A4 (en)	2008-06-11	PHARMACEUTICAL COMPOSITION CONTAINING IRBESARTAN
MX2009008084A (es)	2009-10-12	Derivados de 5,6,7,8-tetrahidropteridina como inhibidores de hsp90.
WO2007012019A3 (en)	2007-11-01	Medicaments containing famotidine and ibuprofen and administration of same
FR2878161B1 (fr)	2008-10-31	Forme medicamenteuse orale, solide et concue pour eviter le mesusage
PT2459153E (pt)	2013-12-10	Composição farmacêutica ou cosmética ou dietética tendo o efeito de favorecer a pigmentação capilar
CL2009001267A1 (es)	2010-12-31	Compuestos derivados de triciclos nitrogenados, con actividad antibacteriana; procedimiento de preparacion; composicion farmceutica que los comprende; para el tratamiento de la tuberculosis.
MX2008011020A (es)	2008-09-08	Compuestos de receptor sigma.
WO2009088673A3 (en)	2009-09-11	Pharmaceutical composition
UA90893C2 (ru)	2010-06-10	Пероральная дозированная форма производных гемцитабина
WO2003002125A3 (en)	2003-11-06	Combination of aminosugars and cysteine or cysteine derivatives
MX2009005912A (es)	2009-07-22	Derivados de etilamina-fenilo heterociclilo sustituidos, su preparacion y uso como medicamentos.
TW200628468A (en)	2006-08-16	Bicyclononene derivatives
BRPI0907203A2 (pt)	2015-07-14	Forma galênica para a administração de triptanos via transmucosa oral
WO2007083173A3 (en)	2013-10-17	Mononucleotides and mononucleosides for use in therapy